Literature DB >> 7838335

Surgical results of 100 intramedullary tumors in relation to accompanying syringomyelia.

M Samii1, J Klekamp.   

Abstract

During the period from 1977 to August 1992, 100 intramedullary tumors in 94 patients were operated on in the Department of Neurosurgery at the Nordstadt Hospital in Hannover, Germany. Of these, 45% presented with associated syringes. A syrinx was more likely to be found above (49%) than below (11%) the tumor level. In 40%, a syrinx could be identified above and below the tumor level. Ependymomas and hemangioblastomas were the most common tumor types to be associated with syringes. Astrocytomas tended to demonstrate syringes less often. Regardless of histology, the higher the spinal level, the more likely a syrinx was encountered. In general, the presence of an associated syrinx favored the resectability of the tumor, because it indicated a displacing rather than an infiltrating tumor. Patients with syringomyelia tended to recover from surgery sooner. However, surgical results and long-term prognosis were not influenced significantly by an associated syrinx. The most important factor determining long-term outcome was the preoperative level of neurological function. We propose that factors independent of the tumor, disturbances of cerebrospinal fluid and extracellular fluid flow in particular, have major roles in the pathogenesis of syrinx formation associated with intramedullary tumors.

Entities:  

Mesh:

Year:  1994        PMID: 7838335     DOI: 10.1227/00006123-199411000-00010

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  54 in total

1.  Management of intramedullary tumors in children: analysis of 82 operated cases.

Authors:  Sumit Bansal; Ashish Suri; Sachin A Borkar; Shashank Sharad Kale; Manmohan Singh; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2012-07-07       Impact factor: 1.475

Review 2.  Acquired pathology of the pediatric spine and spinal cord.

Authors:  Susan Palasis; Laura L Hayes
Journal:  Pediatr Radiol       Date:  2015-09-07

Review 3.  Unraveling the riddle of syringomyelia.

Authors:  Dan Greitz
Journal:  Neurosurg Rev       Date:  2006-05-31       Impact factor: 3.042

4.  Outcome predictors and complications in the management of intradural spinal tumours.

Authors:  M D Jenkinson; C Simpson; R S Nicholas; J Miles; G F G Findlay; T J D Pigott
Journal:  Eur Spine J       Date:  2005-12-23       Impact factor: 3.134

5.  A single-center experience with eccentric syringomyelia found with pediatric Chiari I malformation.

Authors:  Nimer Adeeb; Martin M Mortazavi; Mohammadali M Shoja; R Shane Tubbs; W Jerry Oakes; Curtis J Rozzelle
Journal:  Childs Nerv Syst       Date:  2012-04-26       Impact factor: 1.475

Review 6.  Hemangioblastomas of the lower spinal region: report of four cases with preoperative embolization and review of the literature.

Authors:  Alessandra Biondi; Giuseppe K Ricciardi; Tierry Faillot; Laurent Capelle; Rémy Van Effenterre; Jacques Chiras
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

7.  Diagnosis and microsurgical treatment of spinal hemangioblastoma.

Authors:  Xuezhen Li; Jianzhen Wang; Jianxing Niu; Jiakang Hong; Yaohui Feng
Journal:  Neurol Sci       Date:  2016-02-23       Impact factor: 3.307

8.  Surgical outcome and prognostic factors of spinal intramedullary ependymomas in adults.

Authors:  Ung Kyu Chang; Woo Jin Choe; Sang Kee Chung; Chun Kee Chung; Hyun Jib Kim
Journal:  J Neurooncol       Date:  2002-04       Impact factor: 4.130

9.  Intramedullary hemangioblastomas: timing of surgery, microsurgical technique and follow-up in 23 patients.

Authors:  A Boström; F-J Hans; P C Reinacher; T Krings; U Bürgel; J M Gilsbach; M H T Reinges
Journal:  Eur Spine J       Date:  2008-04-04       Impact factor: 3.134

Review 10.  Intramedullary lesions of the conus medullaris: differential diagnosis and surgical management.

Authors:  Florian H Ebner; Florian Roser; Marcus A Acioly; Wolfgang Schoeber; Marcos Tatagiba
Journal:  Neurosurg Rev       Date:  2008-09-27       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.